An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

PHASE3CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Secondary Hypogonadism

Interventions

DRUG

Androxal

All Listed Sponsors

lead

Repros Therapeutics Inc.

INDUSTRY

NCT01739582 - An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism | Biotech Hunter | Biotech Hunter